Stock 600165 NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

News Ningxia Zhongke Biotechnology Co., Ltd

Equities

600165

CNE000000W47

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 09/05/2024 BST 		5-day change 1st Jan Change
1.49 CNY -5.10% Intraday chart for Ningxia Zhongke Biotechnology Co., Ltd -12.87% -55.92%
04-29 Ningxia Zhongke Biotechnology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-26 Ningxia Zhongke Biotechnology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ningxia Zhongke Biotechnology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Ningxia Zhongke Biotechnology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Chinese Securities Regulator Warns Zhongke Biotechnology Over Late Disclosure of Unit's Suspension
MT
China stocks roughly flat as sentiment remains subdued; HK shares up
RE
China stocks jump on strong PMI data
RE
Court Orders Freezing of Zhongke Biotechnology's Bank Accounts Worth 2.6 Million Yuan
MT
Benchmark Mortgage Rate Cuts Boost Chinese Stocks; Zhongke Biotechnology Jumps 5%
MT
Zhongke Biotechnology's Chairman Resigns
MT
Ningxia Zhongke Biotechnology Co., Ltd(XSSC:600165) dropped from S&P Global BMI Index
CI
Zhongke Biotechnology Terminates Partnership With New Materials Firm
MT
Ningxia Zhongke Biotechnology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Ningxia Zhongke Biotechnology Co., Ltd(XSSC:600165) added to S&P Global BMI Index
CI
Ningxia Zhongke Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Ningxia Zhongke Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Ningxia Zhongke Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Shouguang Jintou New Material Technology Co., Ltd. cancelled the acquisition of an unknown stake in Ningxia Zhongke Biotechnology Co., Ltd. from Shanghai Zhongneng Enterprise Development Co., Ltd.
CI
Zhongke Biotechnology Sees Loss Widening for 2022
MT
Zhongke Biotechnology Ends Agreement With Guiyuan Biotechnology
MT
Ningxia Zhongke Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Shouguang Jintou New Material Technology Co., Ltd. signed a Share Transfer Intention Agreement to acquire an unknown stake in Ningxia Zhongke Biotechnology Co., Ltd. from Shanghai Zhongneng Enterprise Development Co., Ltd.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 600165 Stock
  4. News Ningxia Zhongke Biotechnology Co., Ltd